Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes

Type 2 diabetes, characterized by dysfunction of pancreatic β-cells and insulin resistance in peripheral organs, accounts for more than 90% of all diabetes. Despite current developments of new drugs and strategies to prevent/treat diabetes, there is no ideal therapy targeting all aspects of the dise...

Full description

Bibliographic Details
Main Authors: Sevda Gheibi, Tania Singh, Joao Paulo M. C. M. da Cunha, Malin Fex, Hindrik Mulder
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/11/2465
_version_ 1797548132738793472
author Sevda Gheibi
Tania Singh
Joao Paulo M. C. M. da Cunha
Malin Fex
Hindrik Mulder
author_facet Sevda Gheibi
Tania Singh
Joao Paulo M. C. M. da Cunha
Malin Fex
Hindrik Mulder
author_sort Sevda Gheibi
collection DOAJ
description Type 2 diabetes, characterized by dysfunction of pancreatic β-cells and insulin resistance in peripheral organs, accounts for more than 90% of all diabetes. Despite current developments of new drugs and strategies to prevent/treat diabetes, there is no ideal therapy targeting all aspects of the disease. Restoration, however, of insulin-producing β-cells, as well as insulin-responsive cells, would be a logical strategy for the treatment of diabetes. In recent years, generation of transplantable cells derived from stem cells in vitro has emerged as an important research area. Pluripotent stem cells, either embryonic or induced, are alternative and feasible sources of insulin-secreting and glucose-responsive cells. This notwithstanding, consistent generation of robust glucose/insulin-responsive cells remains challenging. In this review, we describe basic concepts of the generation of induced pluripotent stem cells and subsequent differentiation of these into pancreatic β-like cells, myotubes, as well as adipocyte- and hepatocyte-like cells. Use of these for modeling of human disease is now feasible, while development of replacement therapies requires continued efforts.
first_indexed 2024-03-10T14:54:07Z
format Article
id doaj.art-a36c1ad6d7594934829fc0ce534f93b9
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T14:54:07Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-a36c1ad6d7594934829fc0ce534f93b92023-11-20T20:44:22ZengMDPI AGCells2073-44092020-11-01911246510.3390/cells9112465Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of DiabetesSevda Gheibi0Tania Singh1Joao Paulo M. C. M. da Cunha2Malin Fex3Hindrik Mulder4Unit of Molecular Metabolism, Lund University Diabetes Centre, Jan Waldenströms gata 35, Box 50332, SE-202 13 Malmö, SwedenUnit of Molecular Metabolism, Lund University Diabetes Centre, Jan Waldenströms gata 35, Box 50332, SE-202 13 Malmö, SwedenUnit of Molecular Metabolism, Lund University Diabetes Centre, Jan Waldenströms gata 35, Box 50332, SE-202 13 Malmö, SwedenUnit of Molecular Metabolism, Lund University Diabetes Centre, Jan Waldenströms gata 35, Box 50332, SE-202 13 Malmö, SwedenUnit of Molecular Metabolism, Lund University Diabetes Centre, Jan Waldenströms gata 35, Box 50332, SE-202 13 Malmö, SwedenType 2 diabetes, characterized by dysfunction of pancreatic β-cells and insulin resistance in peripheral organs, accounts for more than 90% of all diabetes. Despite current developments of new drugs and strategies to prevent/treat diabetes, there is no ideal therapy targeting all aspects of the disease. Restoration, however, of insulin-producing β-cells, as well as insulin-responsive cells, would be a logical strategy for the treatment of diabetes. In recent years, generation of transplantable cells derived from stem cells in vitro has emerged as an important research area. Pluripotent stem cells, either embryonic or induced, are alternative and feasible sources of insulin-secreting and glucose-responsive cells. This notwithstanding, consistent generation of robust glucose/insulin-responsive cells remains challenging. In this review, we describe basic concepts of the generation of induced pluripotent stem cells and subsequent differentiation of these into pancreatic β-like cells, myotubes, as well as adipocyte- and hepatocyte-like cells. Use of these for modeling of human disease is now feasible, while development of replacement therapies requires continued efforts.https://www.mdpi.com/2073-4409/9/11/2465adipocyteβ-cellsdiabeteshepatocyteinsulin resistanceiPSC
spellingShingle Sevda Gheibi
Tania Singh
Joao Paulo M. C. M. da Cunha
Malin Fex
Hindrik Mulder
Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
Cells
adipocyte
β-cells
diabetes
hepatocyte
insulin resistance
iPSC
title Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
title_full Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
title_fullStr Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
title_full_unstemmed Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
title_short Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
title_sort insulin glucose responsive cells derived from induced pluripotent stem cells disease modeling and treatment of diabetes
topic adipocyte
β-cells
diabetes
hepatocyte
insulin resistance
iPSC
url https://www.mdpi.com/2073-4409/9/11/2465
work_keys_str_mv AT sevdagheibi insulinglucoseresponsivecellsderivedfrominducedpluripotentstemcellsdiseasemodelingandtreatmentofdiabetes
AT taniasingh insulinglucoseresponsivecellsderivedfrominducedpluripotentstemcellsdiseasemodelingandtreatmentofdiabetes
AT joaopaulomcmdacunha insulinglucoseresponsivecellsderivedfrominducedpluripotentstemcellsdiseasemodelingandtreatmentofdiabetes
AT malinfex insulinglucoseresponsivecellsderivedfrominducedpluripotentstemcellsdiseasemodelingandtreatmentofdiabetes
AT hindrikmulder insulinglucoseresponsivecellsderivedfrominducedpluripotentstemcellsdiseasemodelingandtreatmentofdiabetes